ExploreWatchlistsPricing
  1. US-listed companies
  2. Atara Biotherapeutics, Inc.
  3. Financials
  4. Operating expenses

Atara Biotherapeutics, Inc. (ATRA)

Market cap
$27.72M
P/E ratio
SummaryFinancials
Period EndOperating expenses (Million USD)YoY (%)
Dec 31, 2024212-25.37%
Dec 31, 2023285-17.29%
Dec 31, 2022344-4.63%
Dec 31, 2021361+16.74%
Dec 31, 2020309+4.52%
Dec 31, 2019296+24.70%
Dec 31, 2018237+95.10%
Dec 31, 2017122+49.59%
Dec 31, 201681+39.00%
Dec 31, 201558+107.59%
Dec 31, 201428

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat